Case number 2017-1033
Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | CLASSEN IMMUNOTHERAPIES, INC. v. ELAN PHARMACEUTICALS, INC. [RULE 36 JUDGMENT] [nonprecedential] (0) |
| Jun 12, 2018 | 43 | The petition for writ of certiorari, [17-1409], filed on 03/26/2018, was Denied on 06/11/2018. [528600] [JAB] [Entered: 06/12/2018 08:51 AM] (1) |
| Apr 18, 2018 | 42 | Petition for writ of Certiorari filed on 03/26/2018, and placed on the docket 04/10/2018, in the Supreme Court of the United States. Supreme Court #: 17-1409, Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc. [514907] [JAB] [Entered: 04/18/2018 02:20 PM] (2) |
| Apr 11, 2018 | 41 | Petition for writ of Certiorari filed on 01/16/2018, and placed on the docket 04/10/2018, in the Supreme Court of the United States. Supreme Court #: 17-1409, Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc. [512578] [JAB] [Entered: 04/11/2018 03:42 PM] (1) |
| Nov 27, 2017 | 40 | Mandate issued to the United States District Court for the District of Maryland. Costs taxed in the amount of $251.76. Service as of this date by Clerk of Court. [478181] [JAB] [Entered: 11/27/2017 12:39 PM] (1) |
| Oct 31, 2017 | 39 | Bill of Costs for Appellee Elan Pharmaceuticals, Inc.. Service: 10/31/2017 by email. Objection to Bill of Costs due on 11/14/2017. [471938] [James Monroe] [Entered: 10/31/2017 01:41 PM] (0) |
| Oct 17, 2017 | 38 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (FCR 36). (For the Court: Prost,Chief Judge; Lourie,Circuit Judge and Taranto,Circuit Judge). [468265] [JAB] [Entered: 10/17/2017 09:32 AM] (5) |
| Oct 4, 2017 | 37 | Submitted after ORAL ARGUMENT by Joseph J. Zito for Classen Immunotherapies, Inc. and James B. Monroe for Elan Pharmaceuticals, Inc. Panel: Judge: Prost , Judge: Lourie , Judge: Taranto. [465514] [JAB] [Entered: 10/04/2017 12:53 PM] (0) |
| Sep 15, 2017 | 36 | Response to oral argument order from the Appellee Elan Pharmaceuticals, Inc.. designating James B. Monroe as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [461292] [James Monroe] [Entered: 09/15/2017 12:29 PM] (0) |
| Sep 11, 2017 | 35 | Response to oral argument order from the Appellant Classen Immunotherapies, Inc.. designating Joseph J. Zito as arguing attorney. Designated time for argument: 10 minutes. Designated time for rebuttal: 5 minutes. Service of other counsel by Notice of Docket Activity from this entry. [460111] [Joseph Zito] [Entered: 09/11/2017 01:04 PM] (0) |
| Aug 21, 2017 | 34 | NOTICE OF CALENDARING. Panel: 1710C. Case scheduled Oct 04, 2017 10:00 a.m. at the U.S. Court of Appeals for the Second Circuit (40 Foley Square, New York, NY 10007), Courtroom 1505. Response to oral argument order due: 09/15/2017. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [455494] [JAB] [Entered: 08/21/2017 03:43 PM] (0) |
| Apr 12, 2017 | 33 | Notice from Appellee Elan Pharmaceuticals, Inc. regarding conflicts with oral argument (May 1-5 & 8, 2017; June 5 & 9, 2017; July 10 & 11, 2017). Service: 04/12/2017 by email. [423511] [James Monroe] [Entered: 04/12/2017 02:34 PM] (2) |
| Apr 6, 2017 | 32 | 6 paper copies of the Joint Appendix [29] received from Appellant Classen Immunotherapies, Inc. [422162] [KW] [Entered: 04/06/2017 03:04 PM] (0) |
| Apr 5, 2017 | 31 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 04/12/2017. [421646] [CAB] [Entered: 04/05/2017 12:13 PM] (0) |
| Apr 5, 2017 | 30 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Portions of the Joint Appendix [29] were not text-searchable. CORRECTION: All submissions to the court are required to be text-searchable in their entirety. Please ensure future filings are text-searchable. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [421638] [MJL] [Entered: 04/05/2017 11:49 AM] (0) |
| Mar 30, 2017 | 29 | APPENDIX FILED for Classen Immunotherapies, Inc. [27]. Number of Pages: 164. Service: 03/30/2017 by email. The paper copies of the appendix should be received by the court on or before 04/12/2017. [421636] [MJL] [Entered: 04/05/2017 11:46 AM] (164) |
| Mar 30, 2017 | 28 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Elan Pharmaceuticals, Inc.. Service: 03/30/2017 by email. [420511] [James Monroe] [Entered: 03/30/2017 07:30 PM] (4) |
| Mar 30, 2017 | 27 | TENDERED from Appellant Classen Immunotherapies, Inc.. Title: JOINT APPENDIX. Service: 03/30/2017 by email. [420467] [Joseph Zito] [Entered: 03/30/2017 04:32 PM] (164) |
| Mar 28, 2017 | 26 | 6 paper copies of the Reply Brief [25] received from Appellant Classen Immunotherapies, Inc. [419531] [KW] [Entered: 03/28/2017 01:29 PM] (0) |
| Mar 23, 2017 | 25 | REPLY BRIEF FILED for Appellant Classen Immunotherapies, Inc. [24]. Number of Pages: 9. Service: 03/23/2017 by email. The paper copies of the brief should be received by the court on or before 03/31/2017. Appendix is due 03/30/2017. [418866] [CAB] [Entered: 03/24/2017 04:14 PM] (15) |
| Mar 23, 2017 | 24 | TENDERED from Appellant Classen Immunotherapies, Inc.. Title: REPLY BRIEF. Service: 03/23/2017 by email. [418535] [Joseph Zito] [Entered: 03/23/2017 04:44 PM] (15) |
| Mar 21, 2017 | 23 | 6 paper copies of the Response Brief [22] received from Appellee Elan Pharmaceuticals, Inc. [417947] [KW] [Entered: 03/22/2017 02:22 PM] (0) |
| Mar 9, 2017 | 22 | BRIEF FILED for Appellee Elan Pharmaceuticals, Inc. [21]. Number of Pages: 26. Service: 03/09/2017 by email. The paper copies of the brief should be received by the court on or before 03/23/2017. Appellant Classen Immunotherapies, Inc.'s reply brief is due 03/23/2017. [416053] [CAB] [Entered: 03/16/2017 10:32 AM] (37) |
| Mar 9, 2017 | 21 | TENDERED from Appellee Elan Pharmaceuticals, Inc.. Title: RESPONSE BRIEF. Service: 03/09/2017 by email. [414176] [James Monroe] [Entered: 03/09/2017 09:56 PM] (37) |
| Mar 9, 2017 | 20 | Amended Certificate of Interest for the Appellee Elan Pharmaceuticals, Inc.. Service: 03/09/2017 by email. [413957] [James Monroe] [Entered: 03/09/2017 02:22 PM] (4) |
| Jan 13, 2017 | 19 | **TEXT ONLY** ORDER granting motion to extend time to file appellee's principal brief [18] filed by Appellee Elan Pharmaceuticals, Inc. Appellee's brief is due 03/09/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [399144] [AT] [Entered: 01/13/2017 03:30 PM] (0) |
| Jan 13, 2017 | 18 | MOTION of Appellee Elan Pharmaceuticals, Inc. to extend the time to 03/09/2017 at 11:59 pm to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 01/13/2017 by email. [399077] [Paul Browning] [Entered: 01/13/2017 02:02 PM] (9) |
| Dec 15, 2016 | 17 | 6 paper copies of the Opening Brief [16] received from Appellant Classen Immunotherapies, Inc. [391841] [JCP] [Entered: 12/16/2016 01:11 PM] (0) |
| Dec 12, 2016 | 16 | BRIEF FILED for Appellant Classen Immunotherapies, Inc. [15]. Number of Pages: 51. Service: 12/12/2016 by email. The paper copies of the brief should be received by the court on or before 12/19/2016. Appellee Elan Pharmaceuticals, Inc.'s brief is due 01/23/2017. [390704] [CAB] [Entered: 12/13/2016 04:00 PM] (104) |
| Dec 12, 2016 | 15 | TENDERED from Appellant Classen Immunotherapies, Inc.. Title: OPENING BRIEF. Service: 12/12/2016 by email. [390206] [Joseph Zito] [Entered: 12/12/2016 04:41 PM] (104) |
| Nov 23, 2016 | 14 | Corrected Entry of appearance for Luiz Filipie Oliveira as of counsel for Appellant Classen Immunotherapies, Inc.. Service: 11/23/2016 by email. [386047] [Joseph Zito] [Entered: 11/23/2016 07:09 PM] (2) |
| Nov 23, 2016 | 13 | Corrected Entry of appearance for Joseph J. Zito as principal counsel for Appellant Classen Immunotherapies, Inc.. Service: 11/23/2016 by email. [386046] [Joseph Zito] [Entered: 11/23/2016 07:08 PM] (2) |
| Nov 23, 2016 | 12 | Corrected Certificate of Interest for the Appellant Classen Immunotherapies, Inc.. Service: 11/23/2016 by email. [386044] [Joseph Zito] [Entered: 11/23/2016 07:07 PM] (3) |
| Nov 21, 2016 | 11 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [384866] [CAB] [Entered: 11/21/2016 09:59 AM] (0) |
| Oct 27, 2016 | 10 | Corrected Docketing Statement for the Appellant Classen Immunotherapies, Inc.. Service: 10/27/2016 by email. [378078] [Joseph Zito] [Entered: 10/27/2016 01:32 PM] (4) |
| Oct 26, 2016 | 9 | Docketing Statement for the Appellee Elan Pharmaceuticals, Inc.. Service: 10/26/2016 by email. [377904] [James Monroe] [Entered: 10/26/2016 09:33 PM] (4) |
| Oct 26, 2016 | 8 | Certificate of Interest for the Appellee Elan Pharmaceuticals, Inc.. Service: 10/26/2016 by email. [377903] [James Monroe] [Entered: 10/26/2016 09:31 PM] (2) |
| Oct 26, 2016 | 7 | Entry of appearance for Paul W. Browning as of counsel for Appellee Elan Pharmaceuticals, Inc.. Service: 10/26/2016 by email. [377902] [James Monroe] [Entered: 10/26/2016 09:30 PM] (2) |
| Oct 26, 2016 | 6 | Entry of appearance for James B. Monroe as principal counsel for Appellee Elan Pharmaceuticals, Inc.. Service: 10/26/2016 by email. [377901] [James Monroe] [Entered: 10/26/2016 09:28 PM] (2) |
| Oct 26, 2016 | 5 | Certificate of Interest for the Appellant Classen Immunotherapies, Inc.. Service: 10/26/2016 by email. [377801] [Joseph Zito] [Entered: 10/26/2016 03:00 PM] (2) |
| Oct 26, 2016 | 4 | Docketing Statement for the Appellant Classen Immunotherapies, Inc.. Service: 10/26/2016 by email. [377800] [Joseph Zito] [Entered: 10/26/2016 02:58 PM] (4) |
| Oct 26, 2016 | 3 | Entry of appearance for Luiz F. Oliveira as of counsel for Appellant Classen Immunotherapies, Inc.. Service: 10/26/1216 by email. [377799] [Joseph Zito] [Entered: 10/26/2016 02:55 PM] (1) |
| Oct 26, 2016 | 2 | Entry of appearance for Joseph J. Zito as principal counsel for Appellant Classen Immunotherapies, Inc. Service: 10/26/2016 by email. [377798]--[Edited 10/27/2016 by clerk to correct docket text] [Joseph Zito] [Entered: 10/26/2016 02:51 PM] (1) |
| Oct 12, 2016 | 1 | Appeal docketed. Received: 10/06/2016. [373464]Entry of Appearance due 10/26/2016. Certificate of Interest is due on 10/26/2016. Docketing Statement due 10/26/2016. Appellant's brief is due 12/12/2016. [CAB] [Entered: 10/12/2016 11:37 AM] (51) |
